DEONNA WHATLEY: Open Payments
NPI 1164908034 · PRESCOTT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 7 payments from 6 companies in 2025. Trend: 2023 $250 · 2024 $185 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Novo Nordisk Inc | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: REXULTI, Ozempic, BREZTRI, GVOKE HYPOPEN, XIFAXAN, GARDASIL 9.
Industry payments across AR — which companies pay providers there.
